A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
Abstract Background Polycystic ovary syndrome (PCOS) significantly affects women’s health and well-being. To explore the pharmacological basis of the Erxian decoction (EXD) action in PCOS therapy, a network interaction analysis was conducted at the molecular level. Methods The active elements of EXD...
Main Authors: | Lihong Liu, Bo Du, Haiying Zhang, Xiaofei Guo, Zheng Zhou, Aihui Xiu, Chang Liu, Shiyu Su, Hao Ai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Chinese Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13020-018-0201-1 |
Similar Items
-
Erxian Decoction Attenuates TNF-α Induced Osteoblast Apoptosis by Modulating the Akt/Nrf2/HO-1 Signaling Pathway
by: Nani Wang, et al.
Published: (2019-09-01) -
Effects of Chinese herbal formula Erxian decoction for treating osteoporosis: a systematic review
by: Li J, et al.
Published: (2017-01-01) -
GCTOF-MS Combined LC-QTRAP-MS/MS Reveals Metabolic Difference Between Osteoarthritis and Osteoporotic Osteoarthritis and the Intervention Effect of Erxian Decoction
by: Zhenyuan Ma, et al.
Published: (2022-07-01) -
Therapeutic effects of Guilu-Erxian-Glue treatment on oligoasthenospermia: Evidence from network pharmacology, molecular docking, and in vivo experimental validation
by: Jin Ding, et al.
Published: (2022-12-01) -
An update of polycystic ovary syndrome: causes and therapeutics options
by: Abeer M. Rababa’h, et al.
Published: (2022-10-01)